Artis Ventures
Venture capitalActively deployingSan Francisco · Seed–Late Stage · 7 people tracked
Also known as ARTIS · Artis Ventures (Offshore) · ARTIS VENTURES MANAGEMENT, L.P.
Investment thesis
Artis Ventures backs visionary founders working to reinvent the systems that sustain life, from the cellular to the societal level. By catalyzing breakthroughs in fields such as AI, the firm aims to advance a future where health is proactive, personalized, and resilient — enabling humanity not only to survive but to thrive.
Source: firm website, verified Aug 3, 2026.
Team · 7 people
from public directories
What they invest in
from 45 of 131 portfolio companiesBiotech ×21Healthtech ×21Medical Devices ×20Digital Health ×18AI & Machine Learning ×15Deep Tech ×9SaaS ×7Enterprise Software ×6
HQs:United States×21United Kingdom×3Germany×1Denmark×1
Investments · 131 tracked
founders shown can be your intro pathBiotechNorth Chicago, US
Thomas A. Hurwich(Executive Officer)Edward M. Liddy(Director)Timothy J. Richmond(Executive Officer)Glenn F. Tilton(Director)Henry Gosebruch(Executive Officer)Azita Saleki-Gerhardt(Executive Officer)
PartnerStuart Peterson· quoted
Bloom Energy manufactures solid oxide fuel cell systems for onsite power generation at commercial, industrial, and data center facilities.
CleantechEnergyHardware<UNKNOWN>, US
K.R. Sridhar(Founder, Chairman, and CEO)
Freenome develops early-stage cancer detection technology using blood tests to identify cancer in its earliest, most treatable phases.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesLondon
Riley Ennis(Co-Founder and Chief Product Officer)Stuart Lawson(Director)Charles Roberts(Director)Gabriel Otte(Director)
Data analysis and intelligence software for government, defense, and businesses.
Locus Biosciences is a precision medicine company developing bacteriophage products, including CRISPR/Cas antimicrobials, that target and remove pathogenic bacteria from the body without disrupting the microbiome.
AI & Machine LearningBiotechDeep TechHealthtechRaleigh, US
GEOFFREY GLASS(Director)DAVID JOHNSTON(Director)NICK TAYLOR(Executive Officer)PAUL GAROFOLO(Executive Officer, Director)BARY BAILEY(Director)CHUCK BRAMLAGE(Director)
Outpace Bio develops engineered protein technologies and cell therapies to treat solid tumors, focusing on protein design and T cell engineering to improve cancer treatment efficacy and safety.
BiotechDeep TechMedical DevicesSeattle, US
Marc Lajoie(Co-founder & Chief Executive Officer)Scott Boyken(Co-founder & Chief Technology Officer)Stanley Riddell(Co-Founder and Scientific Advisor)Aaron Foster(Executive Officer)Charity Scripture(Executive Officer)Eric Soller(Executive Officer)
Valarian builds ACRA, an infrastructure platform for organizations requiring high levels of control, privacy, and compliance in their digital environments.
Cloud ComputingCybersecurityEnterprise SoftwareLondon, GB
Max Buchan(Co-founder & CEO)Josh McLaughlin(Co-founder & COO)
New York, US
Board seatStuart Peterson· per SEC Form D · $33M raise · filed Sep 2025
San Francisco, US
Board seatVasudev Bailey· per SEC Form D · $63.8M raise · filed Feb 2021
Overt Bio develops cell therapies that link genes to immune functions using genome-scale discovery platforms.
AI & Machine LearningBiotechMedical DevicesNew York, US
Dr. Legut(Co-Founder and CEO)Dr. Sanjana(Co-Founder)Mateusz Legut(Executive Officer, Director)Vasudev Bailey(Director)Sara Choi(Director)Neville Sanjana(Director)
Board seatVasudev Bailey· per SEC Form D
Unnatural Products is a drug discovery platform company that develops synthetic macrocycles to target previously undruggable disease targets.
AI & Machine LearningBiotechDeep TechMedical DevicesSanta Cruz, US
Cameron Pye(Co-Founder & CEO)Joshua Schwochert(Co-Founder & CSO)Vasudev Bailey(Director)
Board seatVasudev Bailey· per SEC Form D
Leveraging AAV gene therapy for safe durable expression of cytokine immunotherapies
Activ Surgical develops digital surgery imaging technology that uses augmented reality, artificial intelligence, and machine learning to help surgeons visualize critical physiological structures during surgery.
AI & Machine LearningHealthtechMedical DevicesBoston, US
Michael Ruehlman(Executive Officer)Emily Casey(Director)David Wells(Director)Peter Kim(Director)Todd Usen(Executive Officer, Director)
BoardAshok Krishnamurthi(Director)
Redefining addiction recovery for the digital age through innovative, next-generation therapeutic tools
Affect provides integrated mental health and addiction treatment through a smartphone app, combining therapy, medication management, and behavioral incentives.
Digital HealthHealthtechMental HealthNew York, US
Kevin Ryan(Director)Kristin Muhlner(Executive Officer, Director)Jeff Rinehart(Director)Jeff DeFlavio(Director)
AI-powered data security and management
ALLInBio develops a precision immunology approach to identify and treat patients genetically predisposed to rapid progression of chronic inflammatory diseases.
BiotechHealthtechMedical Devices
Ark provides a customizable digital platform for venture capital and private equity firms to manage investor communications, performance reporting, and document sharing with their limited partners.
Enterprise SoftwareFintechSaaS
Infrastructure for fully automated manufacture of any human cell type
Revolutionizing the treatment of bacterial disease
Bettani produces dairy-free cheese using a proprietary plant-based protein derived from regenerative crop seeds, offering products with comparable taste, texture, and protein content to conventional dairy cheese.
CleantechFoodTechImpact & Social Good
Developing a breakthrough cellular targeted particle therapy based on BNCT
Building a new infrastructure for cancer care
Eliminating resilient cancer stem cells through precision targeted therapies in solid tumours
Cancer therapeutics as precise as their targets
Building the future of cardiovascular care through non-invasive devices and revolutionary algorithms
Cartography develops antibody-based cancer therapies using single-cell sequencing and computational biology to identify precise cellular targets.
AI & Machine LearningBiotechDeep TechMedical Devices
Max Mumbach(Founding Scientist, Target Discovery)Jeffrey Verboon(Founding Scientist, Computational Biology)Ansu Satpathy(Founder)Kevin Parker(Chief Executive Officer)
The most patient-friendly way to access clinical trials
Cohesity provides cyber resilience software that helps organizations identify and protect the minimal critical datasets and systems needed to restart operations after ransomware attacks or disasters.
Cloud ComputingCybersecurityData & InfrastructureEnterprise SoftwareSan Jose, US
Sanjay Poonen(CEO & President)WILLIAM COUGHRAN(Director)TIMOTHY ROBBINS(Executive Officer)LORENZO MONTESI(Executive Officer)DANIEL WARMENHOVEN(Director)ROB SALMON(Executive Officer)
Conceivable builds AURA, a robotic automation platform that automates manual IVF laboratory procedures using physical AI, aiming to increase accessibility and affordability of in-vitro fertilization treatments.
AI & Machine LearningDeep TechHealthtechMedical DevicesRobotics
Alan Murray(Founder & CEO)Alejandro Chavez-Badiola, MD(Founder & Chief Medical Officer)
Providing a secure virtual infrastructure platform that ensures data sovereignty, operational resilience, and timely privileged communication
Reprogramming biology by writing and delivering big DNA
Eko develops FDA-cleared digital stethoscopes and AI-powered software that enables healthcare professionals to detect and diagnose cardiovascular disease with greater accuracy.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Connor Landgraf(Co-Founder and CEO)Tyler CrouchJason Bellet(Co-Founder and Chief Business Officer)
Diverting non-emergent 911 calls to reduce unnecessary ER visits and improve outcomes for patients, payors, and emergency services
Enklu develops Verse, a location-based attraction platform for venue, resort, and entertainment center operators to create social entertainment experiences.
Gaming
Enterprise networking (Wi-Fi, switches, SD-WAN) with cloud-managed security for campuses & branches
Fabric Genomics provides an AI-based platform for next-generation sequencing (NGS) analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing.
AI & Machine LearningBiotechDigital HealthHealthtechMedical Devices
Martin Reese(Co-Founder, President, and CEO)Erwin Frise(Vice President of Technology and Data Science)
Fertility, longevity and reproductive health care designed around your life, goals and long-term well-being
Creating the infrastructure for next-generation fertility science via genomics, AI and advanced diagnostics
Flash/hybrid storage arrays with predictive analytics (InfoSight) to simplify and optimize data-center storage ops
Repurposing enzymes to create entirely new compounds
Making genomics-driven precision medicine a reality with clinical decision support software
Glyphic Biotechnologies develops ProSE™, a high-throughput de novo protein sequencing technology for analyzing proteomes with single-molecule sensitivity.
BiotechDeep TechBerkeley, US
Joshua Yang(Founder & CEO)Daniel Estandian(Founder)Ed Boyden(Founder)Craig Asher(Director)Jimmy Yun(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- What stage does Artis Ventures invest at?
- Artis Ventures invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What is Artis Ventures's typical check size?
- Artis Ventures typically writes checks of $50K – $25M.
- What sectors does Artis Ventures focus on?
- Artis Ventures focuses on AI & Machine Learning, Biotech, Consumer, Deep Tech, Digital Health, Fintech, Healthtech, Medical Devices.
- Where is Artis Ventures located?
- Artis Ventures is headquartered in San Francisco, US.
- Does Artis Ventures lead rounds?
- Yes, Artis Ventures leads investment rounds.
Co-investors · 55
Abstract is a San Francisco-based venture capital firm managing $1.8 billion in assets, focused on seed and early-stage investments.
Wing is a venture capital firm that backs founders building enterprise, AI, and technology companies.
Sequoia Capital is a venture capital firm that partners with founders to build technology companies, with a strong current focus on artificial intelligence.
RA Capital invests in public and private healthcare and life science companies developing pharmaceuticals, medical devices, and diagnostic tools. The firm operates as a crossover fund across multiple investment stages.
GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.
Founders Fund is a venture capital firm that invests in companies building transformative technologies across defense, space, data analytics, and other frontier sectors.
New Enterprise Associates (NEA) is a venture capital firm that invests in and provides long-term support to founders building new companies.
ARCH Venture Partners is a venture capital firm that backs and helps build transformational companies, with a strong focus on the life sciences and biotech sector.
Vertical Venture Partners is an early-stage venture capital firm that invests exclusively in specific industry verticals, backing founders whose deep, operator-level understanding of a vertical drives their company.
Accel is a venture capital firm that partners with exceptional founding teams, positioning itself as a first partner to startups globally.
Notable Capital is an early-stage venture firm that partners closely with founders, providing hands-on operational support through a platform team of experienced operators across hiring, sales, leadership development, storytelling, and engineering.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, with a portfolio of companies from early stage through growth.
▶43 more co-investors
Battery VenturesACME CapitalMayfield FundMadrona Venture GroupCota CapitalHighland Capital PartnersWhat If VenturesKickstart FundThe Venture CollectiveAstanor VenturesCorrelation VenturesS32TRANSFORMATION CAPITALMolten VenturesAdvance Venture PartnersQuesta CapitalMerck Global Health Innovation FundFaberPsyMed VenturesLightspeed Venture PartnersCraft VenturesLong Journey VenturesFelicis VenturesFoundation CapitalCanaan PartnersSlow VenturesInnovation EndeavorsCanvas VenturesSierra VenturesPolaris PartnersThrive CapitalSalesforce Japan Co.,Ltd.Unusual VenturesDigital Currency GroupPolychain CapitalRadical VenturesPaladin Capital GroupDigitalis VenturesTencent HoldingsRecode VenturesThiel CapitalCowles VenturesNegev Capital
Firms observed investing alongside Artis Ventures, from public investor directories. Shared companies are the overlap with Artis Ventures's recorded portfolio.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
Khosla Ventures is a venture capital firm known for backing bold, contrarian bets in world-class teams that can reshape entire industries.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, with a portfolio of companies from early stage through growth.
New Alliance Capital is a Shanghai-based private equity and venture capital firm founded in 2008, focused on technology-driven sectors. Its backers include state-owned enterprise groups, insurance capital, fund-of-funds, government guidance funds, and listed companies.
Olive Tree Capital invests in technology and life sciences companies, backing entrepreneurs across healthcare, fintech, enterprise, AI/ML, and frontier technology sectors.